Get started
Author

Romina M. Riener

Observed name: Romina Riener
Institution: Synthekine
ORCID: 0000-0001-5005-112X
Observed ORCID: 0000-0001-5005-112X
OpenAlex ID: A5022698692
In vivo CAR T cell generation to treat cancer and autoimmune disease
2025 · Theresa L. Hunter, Yanjie Bao, et al. · Science · 370
Examining the Fish Microbiome: Vertebrate-Derived Bacteria as an Environmental Niche for the Discovery of Unique Marine Natural Products
2012 · Laura M. Sanchez, Weng Ruh Wong, et al. · PLoS ONE · 99
PDF
An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphoma
2021 · Paul-Joseph Aspuria, Sandro Vivona, et al. · Science Translational Medicine · 86
Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory Cells
2017 · Selvakumar Sukumar, Douglas C. Wilson, et al. · Cancer Research · 62
Biofilm Formation and Detachment in Gram-Negative Pathogens Is Modulated by Select Bile Acids
2016 · Laura M. Sanchez, Andrew T. Cheng, et al. · PLoS ONE · 51
PDF
NMDA receptor dysregulation in chronic state: A possible mechanism underlying depression with BDNF downregulation
2014 · Carol E. Vásquez, Romina Riener, et al. · Neurochemistry International · 50
Abstract 1744: STK-012, an alpha/beta selective IL-2 mutein for the activation of the antigen-activated T cells in solid tumor
2021 · Jan Emmerich, Michele Bauer, et al. · Cancer Research · 17
Abstract 5544: IL10/IL2 surrogate cytokine agonists
2022 · Mahalakshmi Ramadass, Sandro Vivona, et al. · Cancer Research · 2
OrthoCARs: Engineered human IL-2/IL-2Rb orthogonal pairs selectively enhance CAR T cell antitumorefficacy
2020 · Paul-Joseph Aspuria, Michael A Bauer, et al. · Blood · 2
Abstract 1801: STK-012, an a/b-selective IL-2 activates tumor antigen specific CD25+ CD8 T cells to reject tumors without acute vascular toxicity
2023 · Martin Oft, Navneet Ratti, et al. · Cancer Research · 1
Abstract 2824: Engineered human IL-2/IL-2Rb orthogonal pairs selectively enhance anti-GPC3 CAR T cells to drive complete responses in solid epithelial tumor models
2022 · Paul-Joseph Aspuria, Marie Semana, et al. · Cancer Research · 1
Treatment of SHIV-infected, ART-suppressed rhesus macaques with bispecific HIVxCD3 DART® molecules
2019 · Daniel M. Gorman, Ming-Tain Lai, et al. · Journal of Virus Eradication · 1
PDF
1041 Preferential stimulation of antigen activated CD25 + CD8 T cells with STK-012, an α/β biased IL-2, avoids capillary leak syndrome and enhances anti-tumor immunity
2026 · In-Young E Jung, Jan Emmerich, et al. · Journal for ImmunoTherapy of Cancer
PDF
Supplementary Figures S1 through S10 from Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory Cells
2023 · Selvakumar Sukumar, Douglas C. Wilson, et al.
PDF
Data from Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory Cells
2023 · Selvakumar Sukumar, Douglas C. Wilson, et al.
Supplementary Methods from Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory Cells
2023 · Selvakumar Sukumar, Douglas C. Wilson, et al.
Supplementary Tables S1 and S2 from Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory Cells
2023 · Selvakumar Sukumar, Douglas C. Wilson, et al.
Abstract 4225: IL-2Rβ/IL-2R γsynthetic cytokines induce activation of human T and NK cells
2022 · Rene de Waal Malefyt, PJ Aspuria, et al. · Cancer Research
Abstract 1512: OrthoCARs: Engineered human IL-2/IL-2Rb orthogonal pairs selectively enhance CAR T cell antitumor efficacy by driving T cell expansion and fitness
2021 · Paul-Joseph P. Aspuria, Sandro Vivona, et al. · Cancer Research
Abstract 3252: OrthoCARs: Engineered human IL-2/IL-2Rb orthogonal pairs selectively enhance CAR T cell anti-tumor efficacy and durability of response
2020 · Paul-Joseph Aspuria, Michele Bauer, et al. · Cancer Research
Works count: 20
Citation count: 742
H-index: 7
I10-index: 7
Year
Topic
Type